Abstract 4370764: Single Chamber (Right Atrial) Leadless Pacemaker to Prevent Ventricular Tachycardia
Abstract
Introduction: Sudden changes in ventricular cycle lengths (or short-long-short [S-L-S] sequences) can initiate polymorphic ventricular tachycardia (VT). This pattern involves a premature ventricular beat (PVC), followed by a compensatory pause and subsequent premature beat. The compensatory pause leading to the long cycle is followed by a prolonged repolarization phase. Suppressing S-L-S sequences with anti-bradycardic pacing may prevent polymorphic VT in at-risk patients. Herein we describe a case of a patient being treated for fungal endocarditis who developed recurrent VT storm in whom anti-bradycardia pacing via a single-chamber right atrial pacemaker prevented further sustained VT episodes. Case: A 69-year-old patient with fungal bioprosthetic aortic valve endocarditis developed sustained VT, for which he was successfully resuscitated. He was prescribed a secondary prevention wearable defibrillator lifevest on discharge, but over a 2-week period the patient received 6 appropriate shocks by his wearable defibrillator for polymorphic and monomorphic VT episodes despite treatment with multiple anti-arrhythmic agents. In-patient telemetry identified S-L-S sequence preceding the VT episodes. Subsequently, a single chamber right atrial leadless pacemaker was placed and programmed to pace at eighty beats per minute. At 8 weeks post-implant, he experienced no further VT episodes (non-sustained or sustained). Discussion: Due to ongoing treatment for fungemia, placement of a transvenous pacing/defibrillator system was a relative contraindication, due to high risk for cardiac device infection. While a subcutaneous ICD could have been implanted with less infectious risk, it does not have pacing function, and would not have prevented further VT episodes. Conclusion: This case highlights a unique management strategy utilizing anti-bradycardia pacing via a single chamber right atrial leadless pacemaker to prevent ventricular arrhythmias triggered by S-L-S sequences when other treatment options were less plausible.
Article Details
Authors (4)
John Weng
Mount Sinai Hospital, New York, New York, United States
Ankita Naraparaju
Mount Sinai Hospital, New York, New York, United States
Eileen Galvani
Mount Sinai Hospital, New York, New York, United States
Marc Miller
Mount Sinai Hospital, New York, New York, United States